Neurogene Inc. (NGNE) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Neurogene Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$30.42
+12.71% today
Market cap
$540M
Overall quality
—
Kronos AI 30-day
+21.4%
7 of 8 simulated paths end higher
Neurogene Inc. (NGNE) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $540M. It trades at $30.42, up 12.71% today. 8 analysts' average target of $80.17 implies +163.5% from today's price. Kronos AI's 30-day forecast is +21.4% (7 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $80.17 |
| Low – high | $46.00 – $166.00 |
| Analysts | 8 |
| Upside to average | +163.5% |
Kronos AI 30-day forecast
| Expected close | $32.76 (+21.4%) |
| Likely range | +2.2% … +43.4% |
| As of | 2026-10-27 |
7 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.